We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$102B
AUM Growth
-$2.04B
Cap. Flow
-$1.16B
Cap. Flow %
-1.13%
Top 10 Hldgs %
10.73%
Holding
2,908
New
180
Increased
1,145
Reduced
1,360
Closed
133

Top Buys

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$214M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$198M
3
UITB icon
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
+$148M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$134M
5
WLK icon
Westlake Corp
WLK
+$97.9M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$243M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$226M
3
AN icon
AutoNation
AN
+$175M
4
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$157M
5
LVS icon
Las Vegas Sands
LVS
+$142M

Sector Composition

Rank Sector Weight
1 Technology 17.64%
2 Industrials 13.83%
3 Financials 12.36%
4 Consumer Discretionary 10.78%
5 Healthcare 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTIC
2676
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$38K ﹤0.01%
12,877
-646
-5% -$1.76K
DRRX
2677
DELISTED
DURECT Corp
DRRX
$36K ﹤0.01%
2,832
-106
-4% -$1.44K
SEEL
2678
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$36K ﹤0.01%
4
– –
CFMS
2679
DELISTED
Conformis, Inc. Common Stock
CFMS
$36K ﹤0.01%
1,093
-34
-3% -$1.2K
AVTX icon
2680
Avalo Therapeutics
AVTX
$983M
$34K ﹤0.01%
5
– –
ATNX
2681
DELISTED
Athenex, Inc. Common Stock
ATNX
$34K ﹤0.01%
+558
New +$40.6K
TNXP icon
2682
Tonix Pharmaceuticals
TNXP
$192M
– –
0
– –
LTRPA
2683
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$31K ﹤0.01%
10,080
-513
-5% -$1.91K
DS
2684
DELISTED
Drive Shack Inc.
DS
$31K ﹤0.01%
11,050
-1,137
-9% -$3.06K
OTLK icon
2685
Outlook Therapeutics
OTLK
$191M
$30K ﹤0.01%
690
-35
-5% -$1.69K
XELA
2686
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$30K ﹤0.01%
+4
New +$41K
SLDB icon
2687
Solid Biosciences
SLDB
$900M
$29K ﹤0.01%
816
-41
-5% -$1.74K
TRVN
2688
DELISTED
Trevena, Inc.
TRVN
$29K ﹤0.01%
37
-3
-8% -$2.54K
SNCR
2689
DELISTED
Synchronoss Technologies
SNCR
$27K ﹤0.01%
+1,234
New +$30.3K
NBEV
2690
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$27K ﹤0.01%
19,287
-992
-5% -$1.8K
ADVM
2691
DELISTED
Adverum Biotechnologies
ADVM
$26K ﹤0.01%
1,192
-58
-5% -$1.48K
NDLS icon
2692
Noodles & Co
NDLS
$107M
$26K ﹤0.01%
275
-3,429
-93% -$335K
REX icon
2693
REX American Resources
REX
$1.41B
$25K ﹤0.01%
1,896
-115,824
-98% -$1.56M
XWEL icon
2694
XWELL
XWEL
$8.66M
$23K ﹤0.01%
776
-37
-5% -$1.19K
OSG
2695
DELISTED
Overseas Shipholding Group Inc.
OSG
$23K ﹤0.01%
10,850
-373
-3% -$935
EMAN
2696
DELISTED
eMagin Corporation
EMAN
$23K ﹤0.01%
10,333
-258
-2% -$684
CARM
2697
DELISTED
Carisma Therapeutics
CARM
$22K ﹤0.01%
1,397
+114
+9% +$5.47K
TTOO
2698
DELISTED
T2 Biosystems, Inc
TTOO
$22K ﹤0.01%
5
– –
BIOR
2699
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$22K ﹤0.01%
+57
New +$24.4K
DMK
2700
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$21K ﹤0.01%
309
-16
-5% -$1.17K
106 107
108
109 110

Similar funds

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Victory Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Victory Capital Management held 2,908 positions worth $102B, down 2% from $104B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q3 2021 filing shows 180 new, 1,145 increased, 1,360 reduced and 133 closed positions. Its largest new stake was Stanley Black & Decker, Inc.: 824,973 shares worth $86.8M. The largest sale was Alphabet (Google) Class C, an estimated $243M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q3 2021 buy was Stanley Black & Decker, Inc.: 824,973 shares worth $86.8M.
  • Victory Capital Management added most to Newell Brands in Q3 2021, an estimated $214M increase.
  • Victory Capital Management's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $243M.
  • Victory Capital Management fully exited Core Mark Holding Co., Inc. in Q3 2021, selling an estimated $122M.
  • Victory Capital Management's ten largest holdings make up 11% of its $102B portfolio in Q3 2021.
  • Victory Capital Management opened 180 new positions and closed 133 in Q3 2021.
  • Victory Capital Management's portfolio value fell 2% quarter-over-quarter to $102B.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.